NCT07445308
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
Clinical trial condition
NMIBC
Explore clinical trials studying NMIBC. Study availability and eligibility vary by location and protocol.
22 public trials
8 recruiting studies
NMIBC trial results
Not yet recruiting
A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.
NCT07064863
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +16 more
- Locations
-
- Kingston Health Sciences Center Kingston, Ontario, Canada
Not yet recruiting
Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial
NCT06982690
- Conditions
- Anesthesia, General, Anesthesia,Spinal, Bladder (Urothelial, Transitional Cell) Cancer, +22 more
- Locations
-
- Department of Urology, College of Medicine, National Taiwan University Taipei, Taiwan
NCT06630871
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
Not yet recruiting
SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt
NCT06588179
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Active, not recruiting
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
NCT05483868
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Arkansas Urology Little Rock, Arkansas, United States
- Tower Urology Los Angeles, California, United States
- Saint John's Cancer Institute Santa Monica, California, United States
- Montefiore Medical Center The Bronx, New York, United States
Active, not recruiting
A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer
NCT06181266
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
- Locations
-
- Michael G. Oefelein Clinical Trials Bakersfield, California, United States
- Duke Health-Duke Cancer Center Durham, North Carolina, United States
- Carolina Urologic Research Center, LLC Myrtle Beach, South Carolina, United States
- Urology San Antonio Medical Center San Antonio, Texas, United States
NCT07798479
- Conditions
- Bladder Cancer, Carcinoma, Disease Attributes, +19 more
- Locations
-
Not specified
NCT07505615
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center, ShangHai, Shanghai, Shanghai Municipality, China
NCT05375903
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma in Situ of Bladder, +18 more
- Locations
-
- Arkansas Urology Little Rock, Arkansas, United States
- UCLA - University of California Los Angeles, California, United States
- Florida Urology Partners, LLC Tampa, Florida, United States
- Johns Hopkins University Baltimore, Maryland, United States